CASSS Bioassays Symposium
April 27-29, 2026
Gaithersburg, Maryland
Visit us at BOOTH #4
Join us at the CASSS Bioassays Symposium in Gaithersburg, MD to discuss how we can help you advance your therapeutic drug program.
Partner with BioAgilytix for CMC Analytical Services
BioAgilytix provides comprehensive CMC analytical development and GMP testing services to support biopharmaceutical programs from early development through commercial release.
As therapeutic modalities grow more complex—from antibody-drug conjugates, mRNA platforms, cell and gene therapies to oligonucleotides—robust analytical strategies are critical to ensuring product quality, regulatory readiness, and successful program progression.
Since 2008, BioAgilytix has partnered with pharmaceutical and biotechnology innovators to solve complex analytical challenges across the product lifecycle. Our teams support programs from pre-IND through commercial release, combining scientific expertise with operational scale to deliver reliable, regulatory-aligned data.
Our CMC analytical capabilities include deep experience in:
-
- Cell-based potency assays
- Molecular and biochemical assays
- Mass spectrometry characterization
- Compendial Testing
- Method development, qualification, and validation
- QC lot release and stability testing under GMP
With GMP testing services available in both the United States and Europe, BioAgilytix supports global programs with integrated development and testing strategies designed to reduce risk and support efficient progression toward commercialization.
Our science-first, consultative approach ensures that each program receives analytical solutions tailored to its unique complexity and regulatory requirements.
Schedule a meeting with our experts on site
Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.
About the event
The CASSS Bioassays Symposium is a premier industry forum that brings together scientific and regulatory experts to discuss current perspectives, strategies, and technologies shaping the field of bioassays. This annual event provides a collaborative environment for researchers, regulators, and industry professionals to explore the evolving role of bioassays in supporting biopharmaceutical development.
The two-day program features scientific presentations, panel discussions, workshops, roundtables, and poster sessions designed to foster meaningful dialogue around analytical approaches, regulatory expectations, and emerging innovations in bioassay development and validation.
Participants gain valuable insights into both the technical and regulatory considerations that influence bioassay strategy across complex therapeutic modalities.
Session topics for 2026 are expected to include areas such as:
- Antibody-Drug Conjugates (ADCs)
- Bispecific and Tri specific Antibodies
- Bioassay Foundations and Method Development
- Cell and Gene Therapies
- Emerging Technologies and Innovations in Bioassays
Schedule a meeting with our experts on site
Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.
© Copyright 2026 BioAgilytix Labs. All rights reserved.
